2017 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
02/13/17T2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results
LEXINGTON, Mass., Feb. 13, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic return to healthcare institutions, today announced operating highlights and financial results for the fourth quarter and year ended December 31, 2016. Recent Operational and Fourth Quarter Performance Highlights: Secured commitments in the fourth quarter that will provide access to an estimated... 
Printer Friendly Version
02/06/17T2 Biosystems to Present at the Leerink Global Healthcare Conference
LEXINGTON, Mass., Feb. 06, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that John McDonough, president and chief executive officer, and Shawn Lynch, chief financial officer, are scheduled to attend and present at the Leerink Global Healthcare Conference on Wednesday, February 15, 2017 at 3:30pm ET at the Lotte New York Palace in New York City. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of t... 
Printer Friendly Version
02/03/17T2 Biosystems Announces 2016 Fourth Quarter and Full-Year Results Release and Conference Call Date
LEXINGTON, Mass., Feb. 03, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that it will release its 2016 fourth quarter and full-year financial results after the market closes on Monday, February 13, 2017.  In conjunction with the release, the Company will host a conference call with the investment community at 4:30 p.m. Eastern Time on Monday, February 13, 2017, to discuss the financial results and other business developments. Interested parties may access the li... 
Printer Friendly Version
01/30/17Study Published in the American Journal of Clinical Pathology Highlights Rapid Detection of Platelet Function Using T2MR® Technology
Study Shows T2MR’s Sensitive Detection of Platelet Function at Similar or Lower Platelet Counts than Traditional Tests  Paper Provides Novel Insight Into Platelet Biology Not Evident Using Plasma-Based Platelet Aggregation Tests LEXINGTON, Mass., Jan. 30, 2017 (GLOBE NEWSWIRE) --  T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced that a new study, “Rapid evaluation of platelet function with T2 magnetic resonanc... 
Printer Friendly Version
01/25/17T2 Biosystems to Host Webinar on the Vital Role of Transformative Diagnostics in Optimizing Antimicrobial Stewardship
Webinar to be hosted by Dr. Michael A. Pfaller, Chief Medical Officer LEXINGTON, Mass., Jan. 25, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic return to healthcare institutions, announced today that the company, in collaboration with LabRoots, will host a webinar on January 31, 2017 beginning at 10:00 a.m. PT/1:00 p.m. ET. The webinar will examine the critical role of r... 
Printer Friendly Version
01/09/17T2 Biosystems Reports Preliminary Fourth Quarter Results and Operational Progress
-- On Track to Meet or Exceed Commercial Guidance and Regulatory Timelines -- LEXINGTON, Mass., Jan. 09, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic return to healthcare institutions, today announced preliminary results for its 2016 fourth quarter. Fourth Quarter Preliminary Performance and Recent Operational Highlights: Secured commitments in the fourth quarter ... 
Printer Friendly Version
01/05/17T2 Biosystems, Inc. Announces $50M Credit Facility
-- Retiring Former Debt Facility; Significantly Decreases Near-Term Cash Needs -- LEXINGTON, Mass., Jan. 05, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products that improve patient health and deliver a strong economic return to healthcare institutions, today announced that it has entered into a $50 million debt facility agreement with CRG LP. The new facility consists of an initial draw of $40 million and the ability to borrow an ad... 
Printer Friendly Version